Datzmann, T.; Schmitt, J.; Fuhrmann, S.; Roessler, M.; Meier, F.; Schoffer, O.
Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010–2020—Cohort Study Based on Administrative Data. Cancers 2021, 13, 6150.
https://doi.org/10.3390/cancers13246150
AMA Style
Datzmann T, Schmitt J, Fuhrmann S, Roessler M, Meier F, Schoffer O.
Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010–2020—Cohort Study Based on Administrative Data. Cancers. 2021; 13(24):6150.
https://doi.org/10.3390/cancers13246150
Chicago/Turabian Style
Datzmann, Thomas, Jochen Schmitt, Saskia Fuhrmann, Martin Roessler, Friedegund Meier, and Olaf Schoffer.
2021. "Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010–2020—Cohort Study Based on Administrative Data" Cancers 13, no. 24: 6150.
https://doi.org/10.3390/cancers13246150
APA Style
Datzmann, T., Schmitt, J., Fuhrmann, S., Roessler, M., Meier, F., & Schoffer, O.
(2021). Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010–2020—Cohort Study Based on Administrative Data. Cancers, 13(24), 6150.
https://doi.org/10.3390/cancers13246150